En Bloc TURBT With Collins Loop vs Conventional TURBT
- Conditions
- Bladder CancerBladder Cancer StageBladder Urothelial CarcinomaBladder NeoplasmUrothelial Carcinoma Recurrent
- Registration Number
- NCT05027412
- Lead Sponsor
- Hospital Universitario de Fuenlabrada
- Brief Summary
This is a prospective, randomized, randomized and single-blind study in patients diagnosed with primary bladder CV. Patients diagnosed by cystoscopy of a bladder tumor and with indication for endoscopic surgical treatment, who meet the inclusion criteria, and who sign the Informed Consent (IC), will be randomized.
- Detailed Description
The main objective of the study is to assess the quality of the resection, defined as the presence of detrusor muscle in the resected tissue.
The secondary objetives are:
* Compare the surgical time, hospital stay, urinary catheterization time and incidence of complications.
* Compare tumor recurrence after one year of follow up.
* Determine the number of re-TURB as a consequence of the absence of muscle layer in the sample or artifacts (Tx)
* Establish the incidence of conversions as a consequence of difficulties in the technique or intraoperative bleeding.
* Compare the degree of satisfaction of the surgeon
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- >18 years old.
- Polypoid / sessile primary tumor.
- < 3 tumors
- Tumor size 10 - 30 mm.
- > 4 tumors
- Size of the largest tumor <1 cm and> 4 cm.
- Tumor located in the bladder dome.
- No visualization of the ureteral meatus.
- Flat or in situ tumor.
- Non-urothelial tumors.
- Clotting disorder or treatment with oral anticoagulants.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method presence of detrusor muscle in the resected sample 1 year of follow up yes/no
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Hospital Universitario de Fuenlabrada
🇪🇸Fuenlabrada, Madrid, Spain
Hospital Universitario de Fuenlabrada🇪🇸Fuenlabrada, Madrid, SpainHugo Otaola Arca, M.D., Ph.D.Principal InvestigatorManuel Álvarez Ardura, M.D.Principal InvestigatorÁlvaro Páez Borda, M.D., Ph.D.Principal Investigator